Work

A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066)

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2017.09.070

Authors: Sharon E. Frey, Kathleen Lottenbach, Irene Graham, Edwin Anderson, Kanwaldeep Bajwa, Ryan C. May, Steven B. Mizel, Aaron Graff, Robert B. Belshe

Institutions: Saint Louis University, Emmes (United States), Wake Forest University Health Sciences, Wake Forest University

Language: English

Topic: Yersinia bacterium, plague, ectoparasites research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Allergy and Infectious Diseases

Award: G2342806175

OpenAlex ID: W2763499109

FWCI: 2.173

Cites: 13

Cited by: 35

Related to: 10